SODIUM OXYBATE IMPROVES PAIN, FATIGUE, AND SLEEP IN FIBROMYALGIA: RESULTS FROM A 14-WEEK RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL

被引:0
|
作者
Swick, T. J. [1 ,2 ]
Alvarez-Horine, S. [3 ]
Zheng, Y. [3 ]
Rothman, Y. [3 ]
Inhaber, N. [3 ]
Holman, A. [4 ]
Smith, T. R. [6 ]
Russell, I [5 ]
机构
[1] Houston Sleep Ctr, Houston, TX USA
[2] Univ Texas Houston, Sch Med, Houston, TX USA
[3] Jazz Pharmaceut Inc, Palo Alto, CA USA
[4] Pacific Rheumatol Associates Inc, Renton, WA USA
[5] Univ Texas Hlth Sci Ctr San Antonio, Univ Clin Res Ctr, Div Clin Immunol & Rheumatol, San Antonio, TX 78229 USA
[6] St Johns Mercy Hlth Care, St Louis, MO USA
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
984
引用
收藏
页码:A321 / A321
页数:1
相关论文
共 50 条
  • [1] FIBROMYALGIA PAIN, FATIGUE, AND SLEEP IMPROVE WITH SODIUM OXYBATE TREATMENT: A 14-WEEK RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED INTERNATIONAL TRIAL
    Swick, T. J.
    Lai, C.
    Benson, B.
    Wang, Y. G.
    Sarzi-Puttini, P.
    [J]. SLEEP, 2010, 33 : A295 - A295
  • [2] Sodium oxybate reduces pain, fatigue, and sleep disturbance and improves functionality in fibromyalgia: Results from a 14-week, randomized, double-blind, placebo-controlled study
    Russell, I. Jon
    Holman, Andrew J.
    Swick, Todd J.
    Alvarez-Horine, Sarah
    Wang, Y. Grace
    Guinta, Diane
    [J]. PAIN, 2011, 152 (05) : 1007 - 1017
  • [3] IMPAIRED SLEEP AND DAYTIME FUNCTIONING AT BASELINE IN SUBJECTS WITH FIBROMYALGIA FROM A 14-WEEK RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF SODIUM OXYBATE
    Swick, T. J.
    Alvarez-Horine, S.
    Zheng, Y.
    Guinta, D.
    Inhaber, N.
    Holman, A.
    Smith, T. R.
    Russell, I
    [J]. SLEEP, 2009, 32 : A330 - A330
  • [4] Pregabalin (Lyrica®) monotherapy for management of fibromyalgia:: Results from a 14-week randomized, double-blind, placebo-controlled international trial
    Zeiher, Bernhardt G.
    Atkinson, Gary
    Pauer, Lynne
    Whelan, Laurence
    [J]. ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S386 - S386
  • [5] Pregabalin monotherapy for relief of pain associated with fibromyalgia: Durability of pain results of a 14-week, double-blind, placebo-controlled trial
    Leon, T.
    Zeiher, B.
    Pauer, L.
    Whalen, E.
    Barrett, J.
    [J]. EUROPEAN PSYCHIATRY, 2008, 23 : S384 - S384
  • [6] A randomized, double-blind, placebo-controlled trial of sodium oxybate in fibromyalgia syndrome [FMS]
    Patkar, A. A.
    Bennett, R. M.
    Michalek, J. E.
    Cook, H.
    Perera, P.
    Masand, P.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S137 - S137
  • [7] Sodium Oxybate Reduces Pain and Improves Function and PGIC in Fibromyalgia: Results from an International, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial
    Swick, Todd
    Spaeth, Michael
    Choy, Ernest
    Alvarez-Horine, Sarah
    Wang, Y. Grace
    Benson, Beverly
    Bennett, Robert
    [J]. NEUROLOGY, 2010, 74 (09) : A280 - A280
  • [8] Sodium oxybate for the treatment of fibromyalgia: A double-blind, placebo-controlled trial
    Mannelli, Paolo
    Patkar, Ashwin
    Kuhn, Cynthia
    Perera, Philip
    [J]. NEUROPSYCHOPHARMACOLOGY, 2006, 31 : S260 - S260
  • [9] Sodium Oxybate Relieves Pain and Improves Function in Fibromyalgia Syndrome A Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial
    Russell, I. Jon
    Perkins, A. Thomas
    Michalek, Joel E.
    [J]. ARTHRITIS AND RHEUMATISM, 2009, 60 (01): : 299 - 309
  • [10] Pregabalin for management of fibromyalgia syndrome (FMS): A 14-week, randomized, double-blind, placebo-controlled, monotherapy trial
    Arnold, Lesley M.
    Russell, I. Jon
    Duan, W. Rachel
    Diri, Erdal
    Young, James P., Jr.
    Martin, Susan
    Sharma, Uma
    Haig, George
    Griesing, Teresa
    [J]. NEUROLOGY, 2007, 68 (12) : A128 - A128